Literature DB >> 15188320

Normal scores for nine maneuvers of the Childhood Myositis Assessment Scale.

Robert M Rennebohm1, Karla Jones, Adam M Huber, Susan H Ballinger, Suzanne L Bowyer, Brian M Feldman, Jeanne Hicks, Ildy M Katona, Carol B Lindsley, Frederick W Miller, Murray H Passo, Maria D Perez, Ann M Reed, Carol A Wallace, Patience H White, Lawrence S Zemel, Peter A Lachenbruch, John R Hayes, Lisa G Rider.   

Abstract

OBJECTIVE: To document and evaluate the scores that normal, healthy children achieve when performing 9 maneuvers of the Childhood Myositis Assessment Scale (CMAS).
METHODS: A total of 303 healthy children, 4-9 years of age, were scored as they performed 9 CMAS maneuvers. The data were then evaluated to determine whether normal scores for some maneuvers are age and sex dependent.
RESULTS: All children were able to achieve maximum possible scores for the supine to prone, supine to sit, floor sit, floor rise, and chair rise maneuvers. All but 2 4-year-olds achieved a maximum possible score for the arm raise/duration maneuver. Performance of the head lift and sit-up maneuvers varied significantly, depending primarily on age. Children in all age groups had less difficulty performing the leg lift than the head lift or sit-up.
CONCLUSION: The normative data generated by this study are of value for interpreting the serial CMAS scores of children with idiopathic inflammatory myopathies.

Entities:  

Mesh:

Year:  2004        PMID: 15188320     DOI: 10.1002/art.20397

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  14 in total

Review 1.  Update on the assessment of children with juvenile idiopathic inflammatory myopathy.

Authors:  Adam M Huber
Journal:  Curr Rheumatol Rep       Date:  2010-06       Impact factor: 4.592

Review 2.  Recent advances in juvenile dermatomyositis.

Authors:  Ann M Reed; Thomas Mason
Journal:  Curr Rheumatol Rep       Date:  2005-04       Impact factor: 4.592

Review 3.  Long-term outcomes in juvenile dermatomyositis: how did we get here and where are we going?

Authors:  Adam Huber; Brian M Feldman
Journal:  Curr Rheumatol Rep       Date:  2005-12       Impact factor: 4.592

4.  The Paediatric Rheumatology International Trials Organisation provisional criteria for the evaluation of response to therapy in juvenile dermatomyositis.

Authors:  Nicolino Ruperto; Angela Pistorio; Angelo Ravelli; Lisa G Rider; Clarissa Pilkington; Sheila Oliveira; Nico Wulffraat; Graciela Espada; Stella Garay; Ruben Cuttica; Michael Hofer; Pierre Quartier; Jose Melo-Gomes; Ann M Reed; Malgorzata Wierzbowska; Brian M Feldman; Miroslav Harjacek; Hans-Iko Huppertz; Susan Nielsen; Berit Flato; Pekka Lahdenne; Harmut Michels; Kevin J Murray; Lynn Punaro; Robert Rennebohm; Ricardo Russo; Zsolt Balogh; Madeleine Rooney; Lauren M Pachman; Carol Wallace; Philip Hashkes; Daniel J Lovell; Edward H Giannini; Boel Andersson Gare; Alberto Martini
Journal:  Arthritis Care Res (Hoboken)       Date:  2010-06-25       Impact factor: 4.794

Review 5.  Criteria to define response to therapy in paediatric rheumatic diseases.

Authors:  Nicolino Ruperto; Angela Pistorio; Angelo Ravelli; Rachana Hasija; Dinara Guseinova; Giovanni Filocamo; Erkan Demirkaya; Clara Malattia; Alberto Martini
Journal:  Eur J Clin Pharmacol       Date:  2010-11-20       Impact factor: 2.953

6.  Reliability of the adult myopathy assessment tool in individuals with myositis.

Authors:  Michael O Harris-Love; Galen Joe; Todd E Davenport; Deloris Koziol; Kristen Abbett Rose; Joseph A Shrader; Olavo M Vasconcelos; Beverly McElroy; Marinos C Dalakas
Journal:  Arthritis Care Res (Hoboken)       Date:  2015-04       Impact factor: 4.794

Review 7.  Measures of adult and juvenile dermatomyositis, polymyositis, and inclusion body myositis: Physician and Patient/Parent Global Activity, Manual Muscle Testing (MMT), Health Assessment Questionnaire (HAQ)/Childhood Health Assessment Questionnaire (C-HAQ), Childhood Myositis Assessment Scale (CMAS), Myositis Disease Activity Assessment Tool (MDAAT), Disease Activity Score (DAS), Short Form 36 (SF-36), Child Health Questionnaire (CHQ), physician global damage, Myositis Damage Index (MDI), Quantitative Muscle Testing (QMT), Myositis Functional Index-2 (FI-2), Myositis Activities Profile (MAP), Inclusion Body Myositis Functional Rating Scale (IBMFRS), Cutaneous Dermatomyositis Disease Area and Severity Index (CDASI), Cutaneous Assessment Tool (CAT), Dermatomyositis Skin Severity Index (DSSI), Skindex, and Dermatology Life Quality Index (DLQI).

Authors:  Lisa G Rider; Victoria P Werth; Adam M Huber; Helene Alexanderson; Anand Prahalad Rao; Nicolino Ruperto; Laura Herbelin; Richard Barohn; David Isenberg; Frederick W Miller
Journal:  Arthritis Care Res (Hoboken)       Date:  2011-11       Impact factor: 4.794

8.  The PRINTO criteria for clinically inactive disease in juvenile dermatomyositis.

Authors:  Dragana Lazarevic; Angela Pistorio; Elena Palmisani; Paivi Miettunen; Angelo Ravelli; Clarissa Pilkington; Nico M Wulffraat; Clara Malattia; Stella Maris Garay; Michael Hofer; Pierre Quartier; Pavla Dolezalova; Inmaculada Calvo Penades; Virginia P L Ferriani; Gerd Ganser; Ozgur Kasapcopur; Jose Antonio Melo-Gomes; Ann M Reed; Malgorzata Wierzbowska; Lisa G Rider; Alberto Martini; Nicolino Ruperto
Journal:  Ann Rheum Dis       Date:  2012-06-26       Impact factor: 19.103

9.  Comparison of children with onset of juvenile dermatomyositis symptoms before or after their fifth birthday in a UK and Ireland juvenile dermatomyositis cohort study.

Authors:  N Martin; P Krol; S Smith; L Beard; C A Pilkington; J Davidson; L R Wedderburn
Journal:  Arthritis Care Res (Hoboken)       Date:  2012-11       Impact factor: 4.794

Review 10.  Consensus-based recommendations for the management of juvenile dermatomyositis.

Authors:  Felicitas Bellutti Enders; Brigitte Bader-Meunier; Eileen Baildam; Tamas Constantin; Pavla Dolezalova; Brian M Feldman; Pekka Lahdenne; Bo Magnusson; Kiran Nistala; Seza Ozen; Clarissa Pilkington; Angelo Ravelli; Ricardo Russo; Yosef Uziel; Marco van Brussel; Janjaap van der Net; Sebastiaan Vastert; Lucy R Wedderburn; Nicolaas Wulffraat; Liza J McCann; Annet van Royen-Kerkhof
Journal:  Ann Rheum Dis       Date:  2016-08-11       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.